SCHEMBL9050210

SCHEMBL9050210

O=C[C@@H]1CCCN1C(=O)[C@H]1NCC(=S)C1C(=O)CC[C@H]1CCc2ccccc2C1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PREP P48147 15/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9048004 1.00 PREP (0.42) PREP
SCHEMBL9048885 0.95 PREP (0.39) PREP
SCHEMBL9047127 0.95 PREP (0.41) PREP
SCHEMBL9046452 0.95 PREP (0.41) PREP
SCHEMBL9049237 0.94 PREP (0.40) PREP
SCHEMBL9048083 0.94 PREP (0.40) PREP
SCHEMBL8146773 0.92 PREP (0.46) PREP
SCHEMBL9048719 0.92 PREP (0.46) PREP
SCHEMBL9048695 0.91 PREP (0.38) PREP
SCHEMBL9046422 0.90 PREP (0.38) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed